Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.
Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.
For the treatment of uterine fibroids and endometriosis.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.